Quest PharmaTech, Inc. (QPT.V)
0.02
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Quest PharmaTech Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2017 | -43.30K% |
| January 31, 2017 | -63.57K% |
| October 31, 2016 | |
| July 31, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | |
| April 30, 2015 | |
| January 31, 2015 | |
| October 31, 2014 | -249.7% |
| July 31, 2014 | |
| April 30, 2014 | |
| January 31, 2014 | |
| October 31, 2013 | |
| July 31, 2013 | |
| April 30, 2013 | |
| January 31, 2013 | |
| October 31, 2012 | |
| July 31, 2012 | |
| April 30, 2012 |
| Date | Value |
|---|---|
| January 31, 2012 | |
| October 31, 2011 | -262.3% |
| July 31, 2011 | -14.84K% |
| April 30, 2011 | -13.26K% |
| January 31, 2011 | -18.28K% |
| October 31, 2010 | -13.26K% |
| July 31, 2010 | -19.17K% |
| April 30, 2010 | -16.98K% |
| January 31, 2010 | -18.39K% |
| October 31, 2009 | -13.71K% |
| July 31, 2009 | -1.11% |
| April 30, 2009 | 25.30% |
| January 31, 2009 | -18.82% |
| October 31, 2008 | -58.05% |
| July 31, 2008 | -4.24% |
| April 30, 2008 | 14.90% |
| January 31, 2008 | -52.93% |
| October 31, 2007 | -28.32K% |
| July 31, 2007 | -20.08K% |
| April 30, 2007 | -81.79% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Kane Biotech, Inc. | -1.65K% |
| BriaCell Therapeutics Corp. | -- |
| Vaxil Bio Ltd. | -- |
| Waverley Pharma, Inc. | -57.65% |
| Goldcoast Resource Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.75% |
| Return on Assets | 20.67% |
| Return on Invested Capital | 20.84% |
| Return on Net Operating Assets | 27.92K% |